Graham Howieson is a pharmaceutical business development consultant, inventor and entrepreneur. He is a highly experienced and competent leader, with an International pedigree covering UK, EU, USA and Asia. An industry pioneer with a forward thinking approach to design and the delivery of new innovative drug delivery and smart packaging solutions for over twenty five years. Worked extensively and exclusively within the pharmaceutical space with leading global enterprises such as: Glaxo Smith Kline, Astra Zeneca, Johnson and Johnson, Sanofi . Building value by solving technical, engineering, regulatory, compliance and brand communication related issues. Working to fulfil a client brief, in terms of the budget, timeline, return on investment for commercial use.
Alongside he has acquired a range of specialist skills which encompass the development of new, emerging technologies to improve the delivery of clinical trials , areas of interest include: intellectual property, digital engagement, bespoke software, SaaS, automation, AI, machine learning, remote compliance monitoring, patient engagement/retention, omni-channel communication, wearables, video enablement tools, VR, hybrid and virtual (supply chain) modelling. The primary objective with all technological advances is to achieve process improvement and increased speed of delivery, aligned with a multi-sensory patient experience.
Increased use of SMART technologies has become ever more prevalent in the delivery of healthcare solutions as well as in the electronic delivery of Patient Information (e-PIL) and leaflets (e-leaflets). This course will provide an overview of the current technologies, the patient and societal benefits and some building blocks for the establishment and delivery of e-PIL and SMART strategic initiatives, providing insight as to where organisations may be most significantly impacted.
This course has been specifically designed to review ways to accelerate the clinical trial process and will provide an excellent opportunity to discuss the opportunities available and how to implement them with an expert in the field of pharmaceutical business development.